Schindler Margrid
Consultant, Paediatric Intensive Care Unit, Great Ormond Street Hospital for Children, London, UK.
Crit Care. 2002 Apr;6(2):111-2. doi: 10.1186/cc1466. Epub 2002 Mar 11.
Over the past 12 years there have been 12 randomised control trials, involving 843 infants, evaluating the effect of salbutamol or albuterol on bronchiolitis. Of these, nine (75%) showed that bronchodilators had no effect. In three studies a small transient improvement in the acute clinical score was seen. Ipratropium bromide had no significant effect. There have been five recent randomised trials involving 225 infants, evaluating the effect of nebulised adrenaline (epinephrine) on bronchiolitis. All five (100%) have shown significant clinical improvement, with reductions in oxygen requirement, respiratory rate and wheeze after nebulised adrenaline. Two showed lower hospital admission rates and earlier discharge with adrenaline. A significant improvement in pulmonary resistance was observed after nebulised adrenaline but not after salbutamol or albuterol. Currently there is no compelling evidence that bronchodilators have a role in the routine management of infants with bronchiolitis. There is better evidence for the use of nebulised adrenaline.
在过去12年里,有12项随机对照试验,涉及843名婴儿,评估了沙丁胺醇或沙丁胺醇对细支气管炎的影响。其中9项(75%)表明支气管扩张剂无效。在三项研究中,急性临床评分有轻微短暂改善。异丙托溴铵无显著效果。最近有五项涉及225名婴儿的随机试验,评估雾化肾上腺素对细支气管炎的影响。所有五项(100%)均显示出显著的临床改善,雾化肾上腺素后氧需求、呼吸频率和喘息均有所降低。两项研究表明,使用肾上腺素可降低住院率并提前出院。雾化肾上腺素后肺阻力有显著改善,但沙丁胺醇或沙丁胺醇后未观察到。目前没有令人信服的证据表明支气管扩张剂在婴儿细支气管炎的常规治疗中起作用。雾化肾上腺素的使用证据更充分。